
Published by: Appian on September 3, 2013
Solving Compliance Changes in the Pharmaceutical Industry
The Foreign Corrupt Practices Act (FCPA) and the Physician Payment Sunshine Act (Sunshine Act) create an enormous compliance burden and expose pharmaceutical companies to financial risk. The most common risks for non-compliance include issues with integrating data on internal and 3rd party systems. 60% of the companies interviewed use manual paper-based systems for interacting with third parties. This greatly increases the risk for potential fraud.
Pharmaceutical companies have the need to:
Appian BPM Software can be used to create mission critical applications that solve the compliance challenges that Pharmaceutical companies face. Learn more about how BPM for Pharmaceuticals helps relieve the burdens of onerous industry regulatory compliance challenges.
Director of Corporate Communications
Appian provides AI automation for the most important business processes at the world’s largest organizations.
On the Appian Platform, customers build AI-powered processes that accelerate work, reduce cost, and manage risk. Our platform is known for its unique power, reliability, and scale. We’ve been automating processes for more than 25 years and have proven expertise in enterprise operations.